Company: DMAAR
Filing Date: 2025-01-23
Form Type: CORRESP
Source: 0001213900-25-005828
Chunk: 0

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-23
Form: CORRESP
Chunk 0
---
January 23, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation
Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Erin Purnell

| Re: | Drugs Made In America Acquisition Corp.            |
|     | Post-Effective Amendment No. 2 to                  |
|     | Registration Statement on Form S-1                 |
|     | File No. 333-281170 (the “Registration Statement”) |

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations
under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Drugs Made In America
Acquisition Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective
at 4:00 p.m., Eastern Time, on January 27, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside
counsel, Loeb & Loeb LLP, request by telephone that such Registration Statement be declared effective.

Pursuant to Rule 460 of the General Rules and Regulations
of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there will be distributed
to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the
proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advises that it has complied and will continue
to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

<div align='center'>* * * [Signature Page Follows]</div>

| Very truly yours, |                   |
| CLEAR STREET LLC, |                   |
| By:               | /s/ Ryan Gerety   |
| Name:             | Ryan Gerety       |
| Title:            | Managing Director |

<div align='center'>[Signature Page to Underwriters’ Acceleration Request Letter]</div>